St. Louis、MOにおける心不全の臨床試験
St. Louisとその周辺地域（約30マイル以内）の拠点で、心不全に関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
被験者募集中第3相
- St. Louis Heart and Vascular, P.C., St Louis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
被験者募集中第3相
- St. Louis Heart and Vascular, P.C., St Louis
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
被験者募集中第2相
- Washington University School of Medicine, St Louis
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
被験者募集中第3相
- Research Site, Bridgeton · 15マイル先
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
被験者募集中第3相
- Washington University Center for Advanced Medicine, St Louis
A Study of LY3971297 in Participants With Heart Failure
被験者募集中第1相
- Washington University, St Louis
Alleviant ALLAY-HFrEF Study
被験者募集中
- Washington University - St Louis, St Louis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
被験者募集中第3相
- Research Site, St Louis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
被験者募集中
- WashU Medicine, St Louis
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
被験者募集中第2相
- Local Institution - 109, St Louis
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
被験者募集中第2/3相
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
被験者募集中第2相
- Washington University Center for Advanced Medicine, St Louis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
被験者募集中観察研究
- St Louis, St Louis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
被験者募集中観察研究
- Washington University, St Louis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
被験者募集中第3相
- Tenax Investigational Site, St Louis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
Alleviant ALLAY-HF Study
被験者募集中
- Washington University - St Louis, St Louis
Assessment of CCM in HF With Higher Ejection Fraction
被験者募集中
- St. Louis Heart and Vascular, Bridgeton · 15マイル先
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
被験者募集中第3相
- Washington Univ School Of Medicine, St Louis
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
被験者募集中第3相
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
被験者募集中第3相
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
被験者募集中第2相
- Washington University School of Medicine, St Louis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
被験者募集中
- St. Louis Heart and Vascular, St Louis
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
被験者募集中第3相
- Washington University, St Louis
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
被験者募集中
- Washington University - Barnes Jewish Health Hospital, St Louis
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
被験者募集中第1/2相
- Washington University in Saint Louis, St Louis
他の都市における心不全の試験
- New York City, NY51件の研究
- Boston, MA44件の研究
- Dallas, TX42件の研究
- Houston, TX36件の研究
- Cleveland, OH33件の研究
- Chicago, IL31件の研究
- Philadelphia, PA31件の研究
- San Francisco, CA29件の研究
- Durham, NC26件の研究
- Atlanta, GA25件の研究
- Kansas City, MO25件の研究
- Baltimore, MD24件の研究
St. Louisにおける他の研究
- 非小細胞肺癌73件の研究
- 乳がん64件の研究
- 転移性癌54件の研究
- 大腸癌50件の研究
- 前立腺がん46件の研究
- がん（全種類）46件の研究
- 肺がん39件の研究
- 卵巣がん38件の研究
- 膵臓がん33件の研究
- 子宮内膜がん29件の研究
- 頭頸部扁平上皮癌28件の研究
- 肥満症25件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。